Crawford faces obstacles in nomination process

Lester Crawford's nomination to head the FDA won committee approval on Wednesday but is still facing some major hurdles before reaching a full Senate vote.
Although the Senate committee on Health, Education, Labor and Pensions approved the nomination, Sens. Patty Murray, D-Wash., and Hillary Clinton, D-N.Y., have placed a hold on Crawford's nomination, blocking immediate consideration of it.
The hold will remain in place until the FDA issues a yes or no decision on allowing OTC sales of Barr Pharmaceuticals' emergency contraceptive Plan B. In January, an FDA advisory panel recommended 24-3 in favor of OTC status for the drug but at press time the agency had yet to make a final determination on the matter.
You must be a registered member of MMM to post a comment.

Email Newsletters

Specialty medicines continue to be a hot category, one in which spending has surged behind products that treat medicine's most complex diseases. This eBook lays out the needs and hurdles along the specialty drug pathway, explaining how stakeholders are working to get meds into patients' hands and ease their experience. Click here to download.